Insiders · Profile

Holdbrook Mark J.

V.P., Clinical Affairs at Tarsus Pharmaceuticals. Filing since 16 Mar 2023. CIK 0001827564

Company
Date
Role
Action
Shares
Amount
Of holding
20 Mar 2023
V.P., Clinical Affairs
Sold at will
198
$2.50K
5.8%
17 Mar 2023
V.P., Clinical Affairs
Sold at will
188
$2.50K
5.3%
16 Mar 2023
V.P., Clinical Affairs
Sold, plan not stated
187
$2.51K
5.0%
3 decisions on file.